NDC codes

FDA NDC Directory
Product NDC (as listed)82867-001Labeler and product segments. Claims need a package NDC.
Product NDC at billing width82867-0001Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
82867-001-01828670001011 BLISTER PACK in 1 CARTON (82867-001-01) / 30 TABLET in 1 BLISTER PACKMarketed from Jun 16, 2023
82867-001-02828670001021 BLISTER PACK in 1 CARTON (82867-001-02) / 30 TABLET in 1 BLISTER PACKMarketed from Jun 16, 2023 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Lodoco
Generic name (nonproprietary)
colchicine tablets 0.5 mg
Active ingredients
Colchicine — .5 mg/1
Dosage form
Tablet
Route
Oral
Labeler
AGEPHA Pharma USA, LLCNDC labeler code 82867
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 215727
Marketing start
Listing expires
Other FDA classes
Alkaloids (Chemical structure)
Identifiers
Product ID 82867-001_58b0922c-5767-1f3f-e063-6394a90a88ccSPL ID 58b0922c-5767-1f3f-e063-6394a90a88ccSPL set ID ff06d68f-d65f-d097-e053-6294a90a7e5fRxCUI 197540, 2663988UNII SML2Y3J35TUPC 0382867001018, 0382867001025
Pharmacologic class
Alkaloid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482867000101 followed by a unit qualifier and the quantity

Package 82867-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

1. INDICATION AND USAGE LODOCO is indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. LODOCO is an alkaloid indicated: • to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82867-001

What is NDC 82867-001?
82867-001 is the product NDC for Lodoco (colchicine tablets 0.5 mg), Colchicine .5 mg/1 tablet, listed with the FDA by AGEPHA Pharma USA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Lodoco (Colchicine Tablets 0.5 mg).
What is the active ingredient?
Colchicine.
Who is the labeler?
AGEPHA Pharma USA, LLC, NDC labeler code 82867. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lodoco?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in